The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
KARE Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/75af4dbb90c54e219eeebabf7885a646 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:75af4dbb90c54e219eeebabf7885a646 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:75af4dbb90c54e219eeebabf7885a6462021-11-05T06:47:57ZThe impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction10.14744/AnatolJCardiol.2020.392672149-22632149-2271https://doaj.org/article/75af4dbb90c54e219eeebabf7885a6462021-03-01T00:00:00Zhttps://anatoljcardiol.com/jvi.aspx?un=AJC-39267&volume=25&issue=3https://doaj.org/toc/2149-2263https://doaj.org/toc/2149-2271Osama A. AminAhmed F. AlaaragKARE PublishingarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENAnatolian Journal of Cardiology, Vol 25, Iss 3, Pp 163-169 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Diseases of the circulatory (Cardiovascular) system RC666-701 |
| spellingShingle |
Diseases of the circulatory (Cardiovascular) system RC666-701 Osama A. Amin Ahmed F. Alaarag The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction |
| format |
article |
| author |
Osama A. Amin Ahmed F. Alaarag |
| author_facet |
Osama A. Amin Ahmed F. Alaarag |
| author_sort |
Osama A. Amin |
| title |
The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction |
| title_short |
The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction |
| title_full |
The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction |
| title_fullStr |
The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction |
| title_full_unstemmed |
The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction |
| title_sort |
impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction |
| publisher |
KARE Publishing |
| publishDate |
2021 |
| url |
https://doaj.org/article/75af4dbb90c54e219eeebabf7885a646 |
| work_keys_str_mv |
AT osamaaamin theimpactofdiscontinuationofsacubitrilvalsartanandshiftingtoangiotensinconvertingenzymeinhibitororangiotensinreceptorblockerinpatientswithheartfailurewithreducedejectionfraction AT ahmedfalaarag theimpactofdiscontinuationofsacubitrilvalsartanandshiftingtoangiotensinconvertingenzymeinhibitororangiotensinreceptorblockerinpatientswithheartfailurewithreducedejectionfraction AT osamaaamin impactofdiscontinuationofsacubitrilvalsartanandshiftingtoangiotensinconvertingenzymeinhibitororangiotensinreceptorblockerinpatientswithheartfailurewithreducedejectionfraction AT ahmedfalaarag impactofdiscontinuationofsacubitrilvalsartanandshiftingtoangiotensinconvertingenzymeinhibitororangiotensinreceptorblockerinpatientswithheartfailurewithreducedejectionfraction |
| _version_ |
1718444476191473664 |